GreenLight Biosciences is a Boston-based biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible
The NDA for Desidustat is based on positive data from the DREAM-ND and DREAM-D Phase 3 trials in patients with Chronic Kidney Disease (CKD) Not on Dialysis and Dialysis
Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth
Nelarabine is in a class of medications called antimetabolites
The system is a compact new addition to the Roche Molecular portfolio, providing efficiency, simplicity and timely results to laboratories of all sizes.
A CRISIL study of 207 pharmaceutical companies that account for 55% of the Rs 3.2 lakh crore-a-year sector revenue indicates as much.
EaseVRx employs the principles of cognitive behavioural therapy and other behavioural therapy techniques for the reduction of pain and pain interference
The aim is to support Pharmacovigilance programme across the countries in the region
This test is inexpensive and results are available immediately as compared to the genetic test
The company expects to begin shipping this product before the end of its fiscal first quarter, ending December 31, 2021
Subscribe To Our Newsletter & Stay Updated
